3.25 USD
↘ 1.16 (26.30%)AT CLOSE (11:59 AM EDT)
Quoin Pharmaceuticals, Ltd. American Depositary Shares
QNRXNASDAQ • USD
4.85
↗ 1.60 (49.17%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
4.85
↗ 1.60 (49.17%)
Market: CLOSED
QNRX is currently priced at $4.84. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Jun 23, 2026.
Open?$4.20
High?$5.07
Low?$3.25
Prev. Close?$4.41
Volume?3.8M
Avg. Volume?30.3K
VWAP?$4.64
Rel. Volume?123.59x
Bid / Ask
Bid?$4.73 × 100
Ask?$4.92 × 100
Spread?$0.19
Midpoint?$4.83
Valuation & Ratios
Market Cap?8.9M
Shares Out?2.0M
P/E Ratio?N/A
P/B Ratio?1.01
EPS?-$8.46
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Employees
6
Market Cap
9.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-10-28
Address
23 HATA'AS STREET
KFAR SABA, 44425
Phone: 97299741444
KFAR SABA, 44425
Phone: 97299741444
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?83
Piotroski F-Score?0/9Weak
Altman Z-Score?-8.92Distress
Confidence?40%Low
Short InterestLow
Short Interest?48.9K
Days to Cover?1.3
Avg Daily Volume37.6K
Settlement Date2026-05-29
Financial Health
Current Ratio?2.87Strong
Quick Ratio?2.87Strong
Cash Ratio?0.58Adequate
Debt/Equity?0.13Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.01CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.4CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-193.7%WEAK▾
S&P3
ROA?-108.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$6.9M
Fundamentals ratios updated end of day